IRIS
POSTORINO, MASSIMILIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.307
EU - Europa 2.031
AS - Asia 1.898
SA - Sud America 296
AF - Africa 40
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 19.581
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.258
SG - Singapore 840
IT - Italia 495
CN - Cina 452
DE - Germania 444
RU - Federazione Russa 260
BR - Brasile 244
UA - Ucraina 205
VN - Vietnam 184
HK - Hong Kong 167
IE - Irlanda 144
FR - Francia 104
GB - Regno Unito 101
FI - Finlandia 72
JP - Giappone 63
SE - Svezia 56
KR - Corea 51
IN - India 41
CA - Canada 35
NL - Olanda 34
PL - Polonia 30
ES - Italia 21
AT - Austria 19
ZA - Sudafrica 17
AR - Argentina 15
UZ - Uzbekistan 13
MX - Messico 12
BD - Bangladesh 11
ID - Indonesia 10
IQ - Iraq 10
BE - Belgio 9
PH - Filippine 9
UY - Uruguay 9
EC - Ecuador 8
TR - Turchia 8
CZ - Repubblica Ceca 7
CO - Colombia 6
MA - Marocco 6
RO - Romania 6
EG - Egitto 5
KE - Kenya 5
KG - Kirghizistan 5
LT - Lituania 5
SA - Arabia Saudita 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
CH - Svizzera 4
CL - Cile 4
DZ - Algeria 4
IR - Iran 4
AL - Albania 3
AU - Australia 3
BG - Bulgaria 3
DK - Danimarca 3
EU - Europa 3
IL - Israele 3
JO - Giordania 3
MY - Malesia 3
PK - Pakistan 3
GR - Grecia 2
PE - Perù 2
PY - Paraguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
CR - Costa Rica 1
ET - Etiopia 1
HN - Honduras 1
HU - Ungheria 1
KH - Cambogia 1
KI - Kiribati 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MN - Mongolia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TG - Togo 1
TH - Thailandia 1
Totale 19.581
Salva come PNG Salva come JPEG
Città #
Woodbridge 4.171
Wilmington 3.747
Houston 3.204
Singapore 477
Fairfield 445
Ashburn 434
Chandler 344
Ann Arbor 330
San Jose 265
Beijing 189
Seattle 176
Hong Kong 166
New York 164
Jacksonville 163
Cambridge 150
Dublin 137
Rome 133
Medford 98
Dearborn 97
The Dalles 78
Dallas 73
Santa Clara 71
Los Angeles 69
Council Bluffs 62
Tokyo 56
Ho Chi Minh City 55
Lawrence 46
Hanoi 43
Zhengzhou 43
Buffalo 37
Munich 37
Moscow 34
Orem 34
Lauterbourg 33
San Diego 32
Milan 29
Chicago 24
São Paulo 23
Helsinki 18
Menlo Park 18
Mülheim 17
Phoenix 17
Shanghai 16
Warsaw 16
Atlanta 15
Bologna 15
Chennai 14
Hefei 14
Denver 13
Johannesburg 13
London 13
Naples 13
Nuremberg 13
San Francisco 13
Engelhard 12
Frankfurt am Main 12
Montreal 12
Redondo Beach 12
Creede 11
Del Norte 11
Stockholm 11
Toronto 11
Nanjing 10
Palo Alto 10
Poplar 10
Amsterdam 9
Brooklyn 9
Brussels 9
Kraków 9
Rio de Janeiro 9
Turku 9
University Park 9
Vienna 9
Boardman 8
Center 8
Da Nang 8
Haiphong 8
Kunming 8
Lappeenranta 8
Mountain View 8
North Bergen 8
Falls Church 7
Jakarta 7
Manchester 7
Montevideo 7
New Delhi 7
Norwalk 7
Porto Alegre 7
Trieste 7
Bari 6
Belo Horizonte 6
Guangzhou 6
Nanchang 6
Nürnberg 6
Saint Petersburg 6
Verona 6
Ankara 5
Columbus 5
Dong Ket 5
Goiânia 5
Totale 16.383
Salva come PNG Salva come JPEG
Nome #
Autodeterminazione e responsabilità sanitaria: le trasfusioni di sangue nei pazienti Testimoni di Geova. 750
Bowel ultrasonography as an aid for diagnosis of intestinal acute graft-versus-host-disease after allogeneic haematopoietic stem cell transplantation 509
Collection of peripheral progenitor cells: a comparison between Amicus and Cobe-Spectra blood cell separators 506
An allele-specific RT-PCR assay to detect type A mutation of the nucleophosmin-1 gene in acute myeloid leukemia 504
Analysis of the expression of adhesion molecules on CD34+ progenitors from bone marrow, umbilical cord blood and G-CSF mobilized peripheral blood 497
Red blood cell depletion of cord blood using hydroxyethylstarch double sedimentation: analysis of 40 cases 473
Identification of a potential topoisomerase II “hotspot” DNA region in the DEK gene in two t(6;9)-positive therapy-related myeloid neoplasms 469
Central Nervous System Involvement in Adult Acute Lymphoblastic Leukemia: Diagnostic Tools, Prophylaxis, and Therapy. 463
Fibrin glue for refractory hemorrhagic cystitis after unrelated marrow, cord blood, and haploidentical hematopoietic stem cell transplantation 461
Minimally differentiated acute myeloid leukemia (AML-MO): Comparison of 25 cases with other French-American-British subtypes 460
Prognostic relevance of the expression of Tdt and CD7 in 335 cases of acute myeloid leukemia 460
Clonal evolution in therapy-related neoplasms 457
P-glycoprotein and BCL-2 levels predict outcome in adult acute lymphoblastic leukaemia 448
The therapeutic use of cord blood 444
SEQUENTIAL THERAPY WITH VAPLD AND BORTEZOMIB AS INDUCTION THERAPY FOR MULTIPLE MYELOMA: A PHARMACOLOGIC COMBINATION TO ACHIEVE COMPLETE REMISSION BEFORE STEM CELL MOBILIZATION 442
SEQUENTIAL THERAPY WITH VAD, BORTEZOMIB AND CYCLOPHOSPHAMIDE AS INDUCTION THERAPY FOR MULTIPLE MYELOMA: A SEQUENTIAL PHARMACOLOGIC COMBINATION TO ACHIEVE COMPLETE REMISSIONS BEFORE STEM CELL TRANSPLANTATION 439
Sezary syndrome in relapse after reduced intensity allogeneic transplant successfully treated with donor lymphocyte infusion 438
A case of oral mycosis fungoides successfully treated by combination of alemtuzumab and chemotherapy 436
Cytokine removal under hemodiafiltration with endogenous reinfusion in acute kidney injury secondary to angioimmunoblastic T-cell lymphoma: a case report 430
Bowel Ultrasonography for Timely Diagnosis of Intestinal Acute Graft Versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation 428
Percutaneus osteoplasty in the treatment of extraspinal painful multiple myeloma lesions. 413
Reduced intensity allogeneic transplantation in primary cutaneous t-cell lymphomas. 408
Percutaneous kyphoplasty: indications and technique in the treatment of vertebral fractures from myeloma 403
Venetoclax: Bcl-2 inhibition for the treatment of chronic lymphocytic leukemia 403
Total parenteral nutrition enriched with glutamine and ω-3 fatty acid in adult patients undergoing autologous stem cell transplantation. 402
Simultaneous occurrence of BCR/ABL1 and RUNX1/RUNX1T1 in a case of therapy-related acute myeloid leukemia 400
High sensitivity of flow cytometry improves detection of occult leptomeningeal disease in acute lymphoblastic leukemia and lymphoblastic lymphoma 396
Children of a lesser god or miracles? An emotional and behavioural profile of children born to mothers on dialysis in Italy: A multicentre nationwide study 2000-12 396
A cluster of Geotrichum clavatum (Saprochaete clavata) infection in haematological patients: a first Italian report and review of literature 395
Percutaneus osteoplasty in the treatment of extraspinal painful multiple myeloma lesions 390
Treatment of Acute Myeloid Leukemia with 20-30% Bone Marrow Blasts 388
Extensive toxic epidermal necrolysis following brentuximab vedotin administration 373
CD90/Thy-1 is preferentially expressed on blast cells of high risk acute myeloid leukaemias 369
Rituximab single agent in age-related Epstein-Barr virus associated B cell disorder complicated by autoimmune anemia and pure red cell aplasia 369
Allogeneic hematopoietic stem cell transplantation in Primary Cutaneous T Cell Lymphoma 369
Reduced-intensity conditioning combined with standard GvHD prophylaxis is tolerable and highly effective for patients with primary cutaneous T-cell lymphomas undergoing allogeneic transplantation in advanced disease stage. 357
Analysis of the expression of adhesion molecules on CD34+ progenitors from bone marrow, umbilical cord and G-CSF stimulated peripheral blood 349
Infections increase the risk of central venous catheter-related thrombosis in adult acute myeloid leukemia. 346
Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia 340
Fludarabine, Cytarabine and Gentuzumab Ozogamicin (FLA-GO) as Salvage Therapy and Bridge to Transplant in Adult Relapsed Acute Myeloid Leukemia (AML) Patients 303
Molecular expression of bone marrow angiogenic factors, cell-cell adhesion molecules and matrix-metallo-proteinases in plasmacellular disorders: A molecular panel to nvestigate disease progression 277
WT1 evaluation in higher-risk myelodysplastic syndrome patients treated with azacitidine 215
Sezary syndrome in relapse after reduced intensity allogeneic transplant successfully treated with donor lymphocyte infusion 167
Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia 154
Fibrin glue for refractory hemorrhagic cystitis after unrelated marrow, cord blood, and haploidentical hematopoietic stem cell transplantation 152
Impaired nodal shrinkage and apoptosis define the independent adverse outcome of NOTCH1 mutated patients under ibrutinib therapy in chronic lymphocytic leukaemia 137
Prophylaxis with Tixagevimab/Cilgavimab in chronic lymphocytic leukaemia, a case control study 121
CT Images in Follicular Lymphoma: Changes after Treatment Are Predictive of Cardiac Toxicity in Patients Treated with Anthracycline-Based or R-B Regimens 118
18F-FDG PET/CT Radiomics for Predicting Therapy Response in Primary Mediastinal B-Cell Lymphoma: A Bi-Centric Pilot Study 109
Telemedicine as a Medical Examination Tool During the Covid-19 Emergency: The Experience of the Onco-Haematology Center of Tor Vergata Hospital in Rome 99
Body composition in patients with follicular lymphoma: asso-ciations between changes in radiomic parameters in patients treated with R-CHOP-like and R-B regimens: LyRa 01F 87
Serum Paraprotein Is Associated with Adverse Prognostic Factors and Outcome, across Different Subtypes of Mature B-Cell Malignancies—A Systematic Review 86
Clinical impact of TP53 disruption in chronic lymphocytic leukemia patients treated with ibrutinib: a campus CLL study 85
Complete remission induced by rituximab-lenalidomide, following CAR-T cell failure, is not associated with CAR-T cell re-expansion in the peripheral blood 73
Association of [18F]-FDG PET/CT-Derived Radiomic Features with Clinical Outcomes and Genomic Profiles in Patients with Chronic Lymphocytic Leukemia 69
Early reappearance of intraclonal proliferative subpopulations in ibrutinib-resistant chronic lymphocytic leukemia 66
Sustained Remission in Relapsed/Refractory Diffuse Large B Cell Lymphoma Following Glofitamab Discontinuation Due to JC Virus Reactivation: Balancing Efficacy and Infectious Risk 64
Measurement of Immunoglobulin Intraclonal diversification refines the clinical impact of IGHV mutational status in chronic lymphocytic leukemia 64
Coexistence of T-Large Granular Lymphocyte Leukemia and Peripheral T Cell Lymphoma-NOS with Indolent Behavior 63
COVID-19 vaccination: Evaluation of risk for protection failure in chronic lymphocytic leukemia patients 57
Expression of HERV-K and embryonic genes in chronic lymphocytic leukemia and their association with therapy regimens 55
COVID-19 vaccination: evaluation of humoral and cellular immunity after the booster dose in chronic lymphocytic leukemia patients 54
Vitamin D and non-Hodgkin lymphomas, trends from an Italian monocentric study 52
Do age, fitness, and concomitant medications influence management and outcomes of patients with CLL treated with ibrutinib? 51
CD49d expression is included in a revised 4-factor model predicting outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: A multicenter real-world experience 44
Transcription factors implicated in late megakaryopoiesis as markers of outcome after azacitidine and allogeneic stem cell transplantation in myelodysplastic syndrome 41
Large clones of Clonal Hematopoiesis affect outcome in Mantle Cell Lymphoma: Results from The FIL MCL0208 Clinical Trial 41
The contribution of IL-10 and IL-6 as potential biomarkers for detecting central nervous system involvement in non-Hodgkin lymphomas 38
Pathogenetic mechanism of macular edema during a treatment with ibrutinib: a case presentation 36
Co-occurrence of angioimmunoblastic T-cell lymphoma and aggressive-refractory plasma-cell neoplasm: Two new cases and literature review 32
Lipegfilgrastim for primary prophylaxis of febrile neutropenia in patients treated for advanced-stage classical hodgkin lymphoma: successful outcomes from a multicenter cohort study 22
Real-World Safety and Effectiveness of Zanubrutinib versus Ibrutinib in CLL: The CLL-ZANU2024 Italian Cohort 22
null 3
Totale 19.837
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.974
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.974
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021218 0 0 0 0 0 0 0 0 0 60 130 28
2021/2022505 23 52 12 31 11 46 18 31 49 37 36 159
2022/2023815 71 69 63 104 47 150 83 71 91 9 41 16
2023/2024496 37 8 30 7 65 164 58 31 9 9 6 72
2024/20251.366 79 251 147 61 30 89 75 133 126 116 117 142
2025/20262.754 255 165 310 283 285 138 323 328 369 298 0 0
Totale 19.837